Home DatasetsExperiment Details
E-GEOD-21123 GSE21123 comparative genomic hybridization by ar… Homo sapiens

Affymetrix SNP array data for soft tissue sarcoma samples

·Released July 5, 2010 ·Updated May 2, 2014
415
Samples
415
Assays
1
Array Platforms
1
References
Description

Soft tissue sarcomas are aggressive mesenchymal cancers that affect more than 10,600 new patients per year in the US, about 40% of whom will die of their disease. Soft tissue sarcomas exhibit remarkable histologic diversity, with more than 50 recognized subtypes, but our knowledge of their genomic alterations is limited. Here we describe the results of an integrative analysis of DNA sequence, copy number, and mRNA expression in 207 samples encompassing seven major subtypes. Genes mutated in more than 5% of samples within a subtype were KIT (in gastrointestinal stromal cell tumors, or GISTs), TP53 (pleomorphic liposarcomas), PIK3CA (myxoid/round-cell liposarcoma), and NF1 (both myxofibrosarcoma and pleomorphic liposarcoma). We show evidence that PIK3CA mutations, found in 18% of myxoid/round-cell liposarcomas, activate AKT in vivo and are associated with poor outcomes. Point mutations in the tumor suppressor gene NF1 were discovered in both myxofibrosarcomas and pleomorphic liposarcomas, while genomic deletions were observed in all subtypes at varying frequencies. Finally, we found that short hairpin RNA-based knockdown of a subset of genes that are amplified in dedifferentiated liposarcoma, including CDK4 and YEATS4, decreased cell proliferation. Our study yields the most detailed map of molecular alterations across diverse sarcoma subtypes to date and provides potential subtype-specific targets for therapy. Human soft tissue sarcoma samples and their matched normal DNA were profiled on Affymetrix 250K SNP (Sty) arrays per manufacturer's instructions

References
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy.
Barretina J, Taylor BS, Banerji S, Ramos AH, Lagos-Quintana M, Decarolis PL, Shah K, Socci ND, Weir BA, Ho A, Chiang DY, Reva B, Mermel CH, Getz G, Antipin Y, Beroukhim R, Major JE, Hatton C, Nicoletti R, Hanna M, Sharpe T, Fennell TJ, Cibulskis K, Onofrio RC, Saito T, Shukla N, Lau C, Nelander S, Silver SJ, Sougnez C, Viale A, Winckler W, Maki RG, Garraway LA, Lash A, Greulich H, Root DE, Sellers WR, Schwartz GK, Antonescu CR, Lander ES, Varmus HE, Ladanyi M, Sander C, Meyerson M, Singer S
PMID: 20601955
Array Platforms
A-AFFY-72
Affymetrix GeneChip Human Mapping 250K Array Sty [Mapping250K_Sty](415 items)
Sample Attributes
cell line
DDLS8817, FU-DD-LS1, LPS141
disease status
GIST:Epitheloid, GIST:Mixed, GIST:N/A, GIST:Spindle, Leiomyosarcoma:N/A, Liposarcoma:Dedifferentiated, Liposarcoma:Myxoid/RC, Liposarcoma:Pleomorphic, MFH:Myxofibrosarcoma, MFH:Pleomorphic, normal, Synovial:Biphasic, Synovial:Monophasic, Synovial:N/A
Organism
Homo sapiens
organism part
Matched normal tissue, Soft-tissue sarcoma
sample id
DDLS8817, FUDDLS1, LPS141, PT100MF, PT101MF, PT102MF, PT103MF, PT104MF, PT105MF, PT106MF, PT107MF, PT108MF, PT109MF, PT10DD, PT110MF, PT111MF, PT112MF, PT113MF, PT114MF, PT115MF, PT116MF, PT117MF, PT118MF, PT119MF, PT11DD, PT120MF, PT121MF, PT122MF, PT123MF, PT124MF, PT125MF, PT126MF, PT127MF, PT128MF, PT129MF, PT12DD, PT130MF, PT131MF, PT132MF, PT133MF, PT134MF, PT135MF, PT136MF, PT137MF, PT138MRC, PT139MRC, PT13DD, PT140MRC, PT141MRC, PT142MRC, PT143MRC, PT144MRC, PT145MRC, PT146MRC, PT147MRC, PT148MRC, PT149MRC, PT14DD, PT150MRC, PT151MRC, PT152MRC, PT153MRC, PT154MRC, PT155MRC, PT156MRC, PT157MRC, PT158MRC, PT159PL, PT15DD, PT160PL, PT161PL, PT162PL, PT163PL, PT164PL, PT165PL, PT166PL, PT167PL, PT168PL, PT169PL, PT16DD, PT170PL, PT171PL, PT172PL, PT173PL, PT174PL, PT175PL, PT176PL, PT177PL, PT178PL, PT179PL, PT17DD, PT180PL, PT181PL, PT182PL, PT183SYN, PT184SYN, PT185SYN, PT186SYN, PT187SYN, PT188SYN, PT189SYN, PT18DD, PT190SYN, PT191SYN, PT192SYN, PT193SYN, PT194SYN, PT195SYN, PT196SYN, PT197SYN, PT198SYN, PT199SYN, PT19DD, PT1DD, PT200SYN, PT201SYN, PT202SYN, PT203SYN, PT204SYN, PT205SYN, PT206SYN, PT207SYN, PT20DD, PT21DD, PT22DD, PT23DD, PT24DD, PT25DD, PT26DD, PT27DD, PT28DD, PT29DD, PT2DD, PT30DD, PT31DD, PT32DD, PT33DD, PT34DD, PT35DD, PT36DD, PT37DD, PT38DD, PT39DD, PT3DD, PT40DD, PT41DD, PT42DD, PT43DD, PT44DD, PT45DD, PT46DD, PT47DD, PT48DD, PT49DD, PT4DD, PT50DD, PT51GT, PT52GT, PT53GT, PT54GT, PT55GT, PT56GT, PT57GT, PT58GT, PT59GT, PT5DD, PT60GT, PT61GT, PT62GT, PT63GT, PT64GT, PT65GT, PT66GT, PT67GT, PT68GT, PT69GT, PT6DD, PT70GT, PT71GT, PT72GT, PT73LMS, PT74LMS, PT75LMS, PT76LMS, PT77LMS, PT78LMS, PT79LMS, PT7DD, PT80LMS, PT81LMS, PT82LMS, PT83LMS, PT84LMS, PT85LMS, PT86LMS, PT87LMS, PT88LMS, PT89LMS, PT8DD, PT90LMS, PT91LMS, PT92LMS, PT93LMS, PT94LMS, PT95LMS, PT96LMS, PT97LMS, PT98LMS, PT99LMS, PT9DD
Experiment Info
Accession
E-GEOD-21123
GEO ID
GSE21123
Type
comparative genomic hybridization by array
Organism
Homo sapiens
Released
July 5, 2010
Updated
May 2, 2014
Submitter
Barry Stephen Taylor、 Jordi Barretina、 Barry S Taylor、 Samuel Singer、 Matthew Meyerson
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com